+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy



Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy



Australian and New Zealand Journal of Obstetrics and Gynaecology 50(3): 253-258



Neonatal abstinence syndrome (NAS) occurs in more than 50% of infants exposed to intrauterine opiates. Maternal opiate dosing has been investigated with conflicting results. The aims of this study were to correlate maternal methadone dose and other risk factors with the development of NAS requiring pharmacological treatment by using easily accessible clinical parameters. Retrospective medical record review of data from 228 opioid dependent pregnant women who delivered 232 live-born infants. Logistic regression analysis was performed on maternal, perinatal and neonatal parameters to identify risk factors for NAS requiring treatment. A prediction model was developed and validated on a separate independent cohort of 188 infants. Of the 232 infants, 172 (74%) infants were treated for NAS. The risk of withdrawal increased by 17% per 5 mg increment of the last maternal methadone dose. The risk was lower for younger gestational ages and for those delivered by Caesarean section compared to those delivered by normal vaginal delivery. Through predictive modeling, gestational age, mode of delivery and last methadone dose were established as risk factors for withdrawal. The model was validated by other statistical measures and its diagnostic performance confirmed on the separate independent cohort. Our data suggests that timing and mode of delivery as well as last maternal methadone dose are significant risk factors for the development of NAS requiring treatment. Based on these clinical parameters, risk stratification for perinatal management of pregnancies associated with opioid dependency and risk prediction for the neonate might now be possible.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054931684

Download citation: RISBibTeXText

PMID: 20618243

DOI: 10.1111/j.1479-828x.2010.01168.x


Related references

Perinatal Risk Factors for the Neonatal Abstinence Syndrome in Infants Born to Women on Methadone Maintenance Therapy. Obstetrical and Gynecological Survey 65(10): 603-604, 2010

Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome. Journal of Perinatal Medicine 35(4): 344-346, 2007

Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?. Archives of Disease in Childhood. Fetal and Neonatal Edition 89(5): F390, 2004

The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment. Journal of Maternal-Fetal and Neonatal Medicine 29(5): 783-788, 2016

Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction 107(Suppl. 1): 45-52, 2012

Does Breast Milk Affect Neonatal Abstinence Syndrome Severity, the Need for Pharmacologic Therapy, and Length of Stay for Infants of Mothers on Opioid Maintenance Therapy During Pregnancy?. Advances in Neonatal Care 16(5): 369-378, 2016

High dose methadone maintenance, (HDMM), and its effect on neonatal abstinence syndrome (NAS). 2007

Morphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome. Journal of Pediatrics 203: 185-189, 2018

Impact of timing of methadone initiation on perinatal outcomes following delivery among pregnant women on methadone maintenance therapy in Ontario. Addiction 114(2): 268-277, 2019

Neonatal Abstinence Syndrome in East Tennessee: Characteristics and Risk Factors among Mothers and Infants in One Area of Appalachia. Journal of Health Care for the Poor and Underserved 28(4): 1393-1408, 2017

Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug and Alcohol Dependence 75(3): 253-260, 2004

Ineffective morphine treatment regimen for the control of Neonatal Abstinence Syndrome in buprenorphine- and methadone-exposed infants. Journal of Developmental Origins of Health and Disease 3(4): 262-270, 2012

Is neonatal abstinence syndrome less severe in infants born in the early term period?. American Journal of Obstetrics and Gynecology 212(1): S250-S251, 2015

High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome. American Journal of Obstetrics and Gynecology 200(1): 70.E1, 2009

Methadone Versus Buprenorphine for Opioid Use Dependence and Risk of Neonatal Abstinence Syndrome. Epidemiology 29(2): 261-268, 2018